Home/Pipeline/croBEE 2.0 System

croBEE 2.0 System

Automated nucleic acid extraction

Approved/CommercialMarketed

Key Facts

Indication

Automated nucleic acid extraction

Phase

Approved/Commercial

Status

Marketed

Company

ALPCO Diagnostics

About ALPCO Diagnostics

Founded in 1991 as the American Laboratory Products Company, ALPCO has evolved from a distributor into a leading global diagnostics firm. Its strategic merger with GeneProof in April 2022 significantly expanded its capabilities in molecular diagnostics. The company now provides integrated platforms for immunodiagnostics and PCR-based molecular diagnostics, serving clinical and research laboratories with high-quality, automated testing solutions.

View full company profile

Therapeutic Areas

Infectious Disease Gastroenterology Specialty Allergy Immunology Diabetes & Obesity Endocrinology

Other Automated nucleic acid extraction Drugs

Drug	Company	Phase	Status
QuickGene Mini480	ADS BIOTEC	Commercial	Active
QuickGene Mini8L	ADS BIOTEC	Commercial	Active
Gene Prep Star NA-480 Plus	ADS BIOTEC	Commercial	Active
QuickGene Auto 12SII	ADS BIOTEC	Commercial	Active
Gene Prep Star NA-480	ADS BIOTEC	Commercial	Active